DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity
暂无分享,去创建一个
S. Thorgeirsson | J. Eyfjord | D. Zimonjic | M. Durkin | N. Popescu | Bao-Zhu Yuan | Xiaoling Zhou | Katrin Gumundsdottir
[1] S. Thorgeirsson,et al. Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap7). , 2002, Gene.
[2] L. Van Aelst,et al. The role of Rho GTPases in disease development. , 2002, Gene.
[3] R. Siebert,et al. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. , 2001, Blood.
[4] L. Qin,et al. Chromosome 8p deletion is associated with metastasis of human hepatocellular carcinoma when high and low metastatic models are compared , 2001, Journal of Cancer Research and Clinical Oncology.
[5] J. Carpten,et al. Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. , 2001, American journal of human genetics.
[6] A. C. Chinault,et al. Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22 , 2001, Oncogene.
[7] K. Arden,et al. p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas. , 2000, Gene.
[8] U. Jaeger,et al. The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Zimonjic,et al. Assignment1 and cloning of mouse Arhgap7 to chromosome 8A4–B2, a conserved syntenic region of human chromosome 8p22→p21 , 2000, Cytogenetic and Genome Research.
[10] Z. Arbieva,et al. High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22. , 2000, Genome research.
[11] Y. Emori,et al. Morphological Changes and Detachment of Adherent Cells Induced by p122, a GTPase-activating Protein for Rho* , 1999, The Journal of Biological Chemistry.
[12] C. Ponting,et al. START: a lipid-binding domain in StAR, HD-ZIP and signalling proteins. , 1999, Trends in biochemical sciences.
[13] J Isola,et al. Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.
[14] F. Matsumura,et al. Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells* , 1998, The Journal of Biological Chemistry.
[15] E. Bergstralh,et al. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer , 1998, Genes, chromosomes & cancer.
[16] M. Werner,et al. Comparative genomic hybridisation for the analysis of chromosomal imbalances in solid tumours and haematological malignancies , 1997, Histochemistry and Cell Biology.
[17] Y. Emori,et al. A dual functional signal mediator showing RhoGAP and phospholipase C‐delta stimulating activities. , 1995, The EMBO journal.
[18] A. Hall,et al. Rho GTPases in transformation and metastasis. , 2002, Advances in cancer research.